Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1998 2
1999 1
2000 1
2001 1
2002 2
2003 1
2004 2
2005 1
2006 2
2007 1
2008 1
2009 1
2010 2
2011 2
2012 3
2013 4
2014 2
2015 1
2016 2
2017 2
2018 2
2019 4
2020 3
2021 6
2022 2
2023 6
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Results by year

Filters applied: . Clear all
Page 1
Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia A.
Mahlangu J, Kaczmarek R, von Drygalski A, Shapiro S, Chou SC, Ozelo MC, Kenet G, Peyvandi F, Wang M, Madan B, Key NS, Laffan M, Dunn AL, Mason J, Quon DV, Symington E, Leavitt AD, Oldenburg J, Chambost H, Reding MT, Jayaram K, Yu H, Mahajan R, Chavele KM, Reddy DB, Henshaw J, Robinson TM, Wong WY, Pipe SW; GENEr8-1 Trial Group. Mahlangu J, et al. Among authors: reding mt. N Engl J Med. 2023 Feb 23;388(8):694-705. doi: 10.1056/NEJMoa2211075. N Engl J Med. 2023. PMID: 36812433 Clinical Trial.
Hemophilic arthropathy of the elbow.
Adams JE, Reding MT. Adams JE, et al. Among authors: reding mt. Hand Clin. 2011 May;27(2):151-63, v. doi: 10.1016/j.hcl.2011.01.007. Hand Clin. 2011. PMID: 21501786 Review.
Inhibitor development.
Astermark J, Lacroix-Desmazes S, Reding MT. Astermark J, et al. Among authors: reding mt. Haemophilia. 2008 Jul;14 Suppl 3:36-42. doi: 10.1111/j.1365-2516.2008.01711.x. Haemophilia. 2008. PMID: 18510520
Immunological aspects of inhibitor development.
Reding MT. Reding MT. Haemophilia. 2006 Dec;12 Suppl 6:30-5; discussion 35-6. doi: 10.1111/j.1365-2516.2006.01363.x. Haemophilia. 2006. PMID: 17123391 Review.
Three-year outcomes of valoctocogene roxaparvovec gene therapy for hemophilia A.
Madan B, Ozelo MC, Raheja P, Symington E, Quon DV, Leavitt AD, Pipe SW, Lowe G, Kenet G, Reding MT, Mason J, Wang M, von Drygalski A, Klamroth R, Shapiro S, Chambost H, Dunn AL, Oldenburg J, Chou SC, Peyvandi F, Millar CM, Osmond D, Yu H, Dashiell-Aje E, Robinson TM, Mahlangu J. Madan B, et al. Among authors: reding mt. J Thromb Haemost. 2024 Apr 12:S1538-7836(24)00184-3. doi: 10.1016/j.jtha.2024.04.001. Online ahead of print. J Thromb Haemost. 2024. PMID: 38614387 Free article.
58 results